United States Bivalirudin Market Report 2016

October 2016 | 124 pages | ID: UAD1085E34CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Bivalirudin

Revenue, means the sales value of Bivalirudin

This report studies sales (consumption) of Bivalirudin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer Healthcare AG (Germany)
• GlaxoSmithKline Plc. (UK)
• Boehringer Ingelheim (Germany)
• Sanofi S.A. (France)
• Abbott India Limited (India)
• Aspen Holdings (South Africa)
• Bristol-Myers Squibb Company (US)
• Eisai Inc. (US)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Bivalirudin in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Bivalirudin Market Report 2016

1 BIVALIRUDIN OVERVIEW

1.1 Product Overview and Scope of Bivalirudin
1.2 Classification of Bivalirudin
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Bivalirudin
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Bivalirudin (2011-2021)
  1.4.1 United States Bivalirudin Sales and Growth Rate (2011-2021)
  1.4.2 United States Bivalirudin Revenue and Growth Rate (2011-2021)

2 UNITED STATES BIVALIRUDIN COMPETITION BY MANUFACTURERS

2.1 United States Bivalirudin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Bivalirudin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Bivalirudin Average Price by Manufactures (2015 and 2016)
2.4 Bivalirudin Market Competitive Situation and Trends
  2.4.1 Bivalirudin Market Concentration Rate
  2.4.2 Bivalirudin Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES BIVALIRUDIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Bivalirudin Sales and Market Share by Type (2011-2016)
3.2 United States Bivalirudin Revenue and Market Share by Type (2011-2016)
3.3 United States Bivalirudin Price by Type (2011-2016)
3.4 United States Bivalirudin Sales Growth Rate by Type (2011-2016)

4 UNITED STATES BIVALIRUDIN SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Bivalirudin Sales and Market Share by Application (2011-2016)
4.2 United States Bivalirudin Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES BIVALIRUDIN MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Bivalirudin Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
  5.2.2 Bivalirudin Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer Healthcare AG (Germany) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
  5.3.2 Bivalirudin Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc. (UK) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
  5.4.2 Bivalirudin Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Boehringer Ingelheim (Germany) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
  5.5.2 Bivalirudin Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Sanofi S.A. (France) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
  5.6.2 Bivalirudin Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Abbott India Limited (India) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
  5.7.2 Bivalirudin Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Aspen Holdings (South Africa) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
  5.8.2 Bivalirudin Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bristol-Myers Squibb Company (US) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
  5.9.2 Bivalirudin Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Eisai Inc. (US) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  5.10.2 Bivalirudin Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)

6 BIVALIRUDIN MANUFACTURING COST ANALYSIS

6.1 Bivalirudin Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Bivalirudin

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Bivalirudin Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Bivalirudin Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES BIVALIRUDIN MARKET FORECAST (2016-2021)

10.1 United States Bivalirudin Sales, Revenue Forecast (2016-2021)
10.2 United States Bivalirudin Sales Forecast by Type (2016-2021)
10.3 United States Bivalirudin Sales Forecast by Application (2016-2021)
10.4 Bivalirudin Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bivalirudin
Table Classification of Bivalirudin
Figure United States Sales Market Share of Bivalirudin by Type in 2015
Table Application of Bivalirudin
Figure United States Sales Market Share of Bivalirudin by Application in 2015
Figure United States Bivalirudin Sales and Growth Rate (2011-2021)
Figure United States Bivalirudin Revenue and Growth Rate (2011-2021)
Table United States Bivalirudin Sales of Key Manufacturers (2015 and 2016)
Table United States Bivalirudin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bivalirudin Sales Share by Manufacturers
Figure 2016 Bivalirudin Sales Share by Manufacturers
Table United States Bivalirudin Revenue by Manufacturers (2015 and 2016)
Table United States Bivalirudin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Bivalirudin Revenue Share by Manufacturers
Table 2016 United States Bivalirudin Revenue Share by Manufacturers
Table United States Market Bivalirudin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Bivalirudin Average Price of Key Manufacturers in 2015
Figure Bivalirudin Market Share of Top 3 Manufacturers
Figure Bivalirudin Market Share of Top 5 Manufacturers
Table United States Bivalirudin Sales by Type (2011-2016)
Table United States Bivalirudin Sales Share by Type (2011-2016)
Figure United States Bivalirudin Sales Market Share by Type in 2015
Table United States Bivalirudin Revenue and Market Share by Type (2011-2016)
Table United States Bivalirudin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Bivalirudin by Type (2011-2016)
Table United States Bivalirudin Price by Type (2011-2016)
Figure United States Bivalirudin Sales Growth Rate by Type (2011-2016)
Table United States Bivalirudin Sales by Application (2011-2016)
Table United States Bivalirudin Sales Market Share by Application (2011-2016)
Figure United States Bivalirudin Sales Market Share by Application in 2015
Table United States Bivalirudin Sales Growth Rate by Application (2011-2016)
Figure United States Bivalirudin Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Bivalirudin Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Bivalirudin Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Bivalirudin Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Bivalirudin Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Bivalirudin Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Bivalirudin Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Bivalirudin Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Bivalirudin Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Bivalirudin Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Bivalirudin Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Bivalirudin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Bivalirudin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bivalirudin
Figure Manufacturing Process Analysis of Bivalirudin
Figure Bivalirudin Industrial Chain Analysis
Table Raw Materials Sources of Bivalirudin Major Manufacturers in 2015
Table Major Buyers of Bivalirudin
Table Distributors/Traders List
Figure United States Bivalirudin Production and Growth Rate Forecast (2016-2021)
Figure United States Bivalirudin Revenue and Growth Rate Forecast (2016-2021)
Table United States Bivalirudin Production Forecast by Type (2016-2021)
Table United States Bivalirudin Consumption Forecast by Application (2016-2021)